Welcome to our dedicated page for Microchip Technology SEC filings (Ticker: MCHP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Microchip Technology Inc. (NASDAQ: MCHP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed information about its semiconductor business, governance and financial condition. As a Delaware corporation headquartered in Chandler, Arizona, Microchip reports as a public company on the Nasdaq Global Select Market, and its regulatory filings are a primary source for understanding MCHP stock.
On this page, investors can review Microchip’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its role as a broadline supplier of semiconductors serving industrial, automotive, consumer, aerospace and defense, communications and computing markets. These reports typically include discussions of segment performance, risk factors, research and development, and other disclosures relevant to the company’s embedded control and semiconductor portfolio.
Microchip also submits current reports on Form 8-K to announce material events. For example, an 8-K dated November 6, 2025 reports the announcement of results for the second quarter of fiscal year 2026, while an 8-K dated August 20, 2025 details the outcomes of the company’s annual meeting of stockholders, including director elections, auditor ratification and an advisory vote on executive compensation.
Definitive proxy statements on Form DEF 14A provide insight into Microchip’s governance, board composition, executive compensation and stockholder voting procedures. The July 7, 2025 proxy statement outlines the agenda for the 2025 annual meeting, the proposals presented to stockholders and information about how to vote.
Stock Titan’s SEC filings page surfaces these documents as they are made available on EDGAR and can pair them with AI-powered summaries that explain key points, such as changes in guidance, voting results or governance matters. Users can quickly locate Forms 10-K, 10-Q, 8-K and DEF 14A related to Microchip Technology, helping them analyze MCHP’s regulatory history, monitor material events and understand the disclosures that shape the company’s profile in the semiconductor industry.
Microchip Technology Incorporated (MCHP) senior vice president of operations reported multiple equity award vesting events and related share withholding transactions. On November 15, 2025, restricted stock units and performance stock units converted into common stock in several tranches, including 870, 840, and 1,465 shares at an exercise price of $51.7 per share, with portions of 243, 234, and 409 shares withheld, coded as dispositions for tax purposes. Additional performance stock units and restricted stock units covering 238 and 452 shares vested on November 17, 2025, with 67 and 126 shares withheld. After these transactions, the officer directly owned 32,522 shares of Microchip common stock.
Microchip Technology (MCHP) Senior VP and CFO, reporting as an indirect owner via a trust, disclosed multiple equity award settlements on November 15 and 17, 2025. Restricted stock units and performance stock units converted into common stock at an exercise price of $51.7 per share, shown as transaction code “M” in both the non-derivative and derivative tables.
Shares were delivered to the executive as the awards vested, while some shares (code “F”) were withheld to cover obligations, leaving 34,381 shares of common stock beneficially owned indirectly by the trust after the final reported transaction. The PSUs are tied to Microchip’s cumulative non-GAAP operating margin targets over 12-quarter periods ending on September 30, 2024 and September 30, 2025, reflecting performance-based compensation.
Microchip Technology (MCHP) reported an insider equity grant by its Chief Operating Officer. On November 6, 2025, the reporting person acquired 846 restricted stock units (RSUs), each representing the right to receive one share of common stock. The RSUs vest in full on November 15, 2026, contingent on continued service. Following the transactions, the filer reported 151,057 shares of common stock held indirectly by a trust, and 846 RSUs held directly.
Microchip Technology (MCHP) insider filed a Form 4 reporting equity awards and holdings. On 11/06/2025, the reporting person received 7,940 restricted stock units (RSUs), each representing one share of common stock, at a stated price of $0. These RSUs vest in full on May 15, 2028, contingent on continued service.
Following the reported transactions, 10,167,682 shares of common stock were beneficially owned indirectly, including 4,261,810 shares held by The Sanghi Trust and 5,905,872 shares held by The Sanghi Family Limited Partnership. The person also held 7,940 derivative securities (RSUs) directly after the award.
Microchip Technology (MCHP) insider filing: the company’s Sr. VP, WW Client Engagement reported the acquisition of 481 restricted stock units (RSUs) on 11/06/2025 (Form 4). Each RSU equals one share of common stock.
The RSUs vest in full on November 15, 2026, subject to continued service. After the reported transactions, the reporting person beneficially owned 16,315 shares of Microchip common stock, held directly.
Microchip Technology (MCHP) Form 4: A Senior VP, Operations reported an award of 460 restricted stock units on 11/06/2025. Each RSU represents the right to receive one share of common stock and will vest in full on November 15, 2026, subject to continued service through that date. Following the reported transaction, the reporting person directly owned 29,736 shares of Microchip Technology common stock.
Microchip Technology (MCHP) reported an insider equity award for its Senior VP and CFO. On 11/06/2025, the executive acquired 634 restricted stock units (RSUs) at a price of $0 under a Form 4 filing.
The RSUs will vest in full on November 15, 2026, with shares delivered upon vesting. Following the reported transactions, the executive beneficially owned 634 derivative securities directly and 30,089 shares of common stock indirectly through a trust.
Microchip Technology (MCHP) filed its quarterly report for the period ended September 30, 2025. Net sales were $1,140.4 million versus $1,163.8 million a year ago, with gross profit of $637.9 million. Operating income was $88.9 million, down from $146.6 million. Net income was $41.7 million; after $27.8 million of Series A preferred dividends, net income attributable to common stockholders was $13.9 million, or $0.03 per diluted share, versus $0.14 a year ago.
For the first six months, net sales were $2,215.9 million versus $2,405.1 million, and operating income was $121.0 million versus $365.7 million. Operating cash flow was $363.7 million. Cash and cash equivalents were $236.8 million, down from $771.7 million at March 31, 2025. The company settled $1.2 billion of 4.250% 2025 notes in September using Commercial Paper and cash; Commercial Paper outstanding was $1.12 billion. Deferred revenue was $385.8 million, including $291.5 million of LTSA deposits. The company paid a $0.455 per‑share common dividend and $27.8 million on its 7.50% Series A preferred, and disclosed an IRS settlement for fiscal years 2007–2015.
Microchip Technology Incorporated furnished an 8‑K to announce its results of operations for the second quarter of fiscal year 2026. The disclosure was provided under Item 2.02 (Results of Operations and Financial Condition) and, as stated, is being furnished pursuant to General Instruction B(2) and is not deemed filed under Section 18 of the Exchange Act.
The company attached a press release as Exhibit 99.1 titled “Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2026.”
Microchip Technology (MCHP) filed a Form 4/A reporting equity awards to its Chief Operating Officer. On 10/01/2025, the officer received 4,874 Restricted Stock Units and 4,875 Performance Stock Units at $0 per unit.
The RSUs vest in full on November 15, 2029. The PSUs are tied to Microchip’s cumulative non-GAAP operating margin over 12 quarters ending September 30, 2028, with a 30.0% target, and will vest on November 15, 2029 if service conditions are met. The amendment corrects the performance target to 30.0%.
Following the reported transactions, the officer holds 151,057 shares of common stock indirectly via a trust, and 4,874 RSUs and 4,875 PSUs directly.